Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EW · against 1,216 other Healthcare companies
Ranked #725 of 1,217 · scores higher than 40% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 40–49, including EW · Click a bar to see the companies
A mix: stronger 3-year revenue growth and revenue growth, but weaker earnings per share growth than most Healthcare peers.
| Metric | EW | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 14.6% | 6.1% | 71% | 33% | |
| Earnings per share growthHigher is better · 682 reported | -75.3% | 9.7% | 5% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 15.0% | 5.8% | 74% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 725 | 86.8B JPY (≈$590M) | 40 | 60 | |
| 725 | 25.3B CNY (≈$3.5B) | 40 | 68 | |
| 725 | 12.6B CNY (≈$1.8B) | 40 | 72 | |
| 725 | 26.6B CNY (≈$3.7B) | 40 | 57 | |
| 725 | 54.9B USD | 40 | 59 | |
| 725 | 2.8B SGD (≈$2.2B) | 40 | 67 | |
| 725 | 9.2B USD | 40 | 47 | |
| 725 | 148.7B INR (≈$1.8B) | 40 | 48 | |
| 725 | 9.7B AUD (≈$6.4B) | 40 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score